Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CPT2 | P23786 | 1/20 | 0.37 |
| ▸ | ACLY | P53396 | 1/20 | 0.37 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.34 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PGD | P52209 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11196284 | 0.80 | TDP1 (0.42) | SLC22A6TDP1SMN1; SMN2CPT2ACLY | |
| SCHEMBL29112587 | 0.78 | TDP1 (0.40) | SLC22A6TDP1SMN1; SMN2CPT2ACLY | |
| SCHEMBL321093 | 0.76 | TDP1 (0.39) | SLC22A6TDP1SMN1; SMN2CPT2ACLY | |
| SCHEMBL1533821 | 0.76 | TDP1 (0.39) | SLC22A6TDP1SMN1; SMN2CPT2ACLY | |
| SCHEMBL4313364 | 0.76 | TDP1 (0.39) | SLC22A6TDP1SMN1; SMN2CPT2ACLY | |
| SCHEMBL5692721 | 0.76 | TDP1 (0.39) | SLC22A6TDP1SMN1; SMN2CPT2ACLY | |
| SCHEMBL14558024 | 0.75 | TDP1 (0.42) | SLC22A6TDP1SMN1; SMN2CPT2ACLY | |
| SCHEMBL723184 | 0.75 | ACLY (0.57) | SLC22A6TDP1SMN1; SMN2CPT2ACLY | |
| SCHEMBL28481021 | 0.75 | TDP1 (0.37) | SLC22A6TDP1SMN1; SMN2CPT2ACLY | |
| SCHEMBL3712481 | 0.73 | TDP1 (0.46) | SLC22A6TDP1SMN1; SMN2CPT2ACLY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106999378-B | Dermatological kit comprising a composition based on hibiscus flower and brischt fruit oil | 医疗品牌研究有限公司 | 2021-10-26 | — | — | CN | claimed |
| CN-101330911-A | Hydroxy-polycarboxylic acid esters: action on nerves and use on skin and mucocutaneous organs or sites | SCOTT EUGENE J VAN (US) | 2008-12-24 | — | — | CN | claimed |
| US-20100172851-A1 | Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites | YU RUEY J | 2010-07-08 | — | — | US | disclosed |
| US-7709014-B2 | Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites | YU RUEY J | 2010-05-04 | — | — | US | disclosed |
| CN-101330911-A | Hydroxy-polycarboxylic acid esters: action on nerves and use on skin and mucocutaneous organs or sites | SCOTT EUGENE J VAN (US) | 2008-12-24 | — | — | CN | disclosed |
| EP-1937246-A2 | HYDROXY-OLIGOCARBOXYLIC ESTERS: EFFECTS ON NERVE AND USE FOR CUTANEOUS AND MUCOCUTANEOUS ORGANS OR SITES | Yu, Ruey J., Dr. (US) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007047486-A2 | HYDROXY-OLIGOCARBOXYLIC ESTERS: EFFECTS ON NERVE AND USE FOR CUTANEOUS AND MUCOCUTANEOUS ORGANS OR SITES | YU RUEY J (US) | 2007-04-26 | — | — | WO | disclosed |
| US-20070093551-A1 | Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites | YU RUEY J | 2007-04-26 | — | — | US | disclosed |
| EP-0290186-A2 | Use of oral compositions comprising anti-calculus agents | PURDUE RESEARCH FOUNDATION (US) | 1988-11-09 | — | — | EP | disclosed |